Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
naquotinib
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
naquotinib
Unique ID
C000627869
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000627869
Entry Term(s)
ASP-8273
ASP8273
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Numbers
47DD4548PB
Heading Mapped to
*Piperazines
*Piperidines
*Pyrazines
*Pyrrolidines
Frequency
8
Note
a third-generation EGFR tyrosine kinase inhibitor (TKI) for the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR mutations
Source
Clin Cancer Res. 2017 Dec 15;23(24):7467-7473.
Date of Entry
2018/08/07
Revision Date
2018/08/07
Expand All
Collapse All
naquotinib
Preferred
Concept UI
M000644186
Registry Numbers
47DD4548PB
Terms
naquotinib
Preferred Term
Term UI
T000945605
Date
08/07/2018
LexicalTag
NON
ThesaurusID
ASP8273
Narrower
Concept UI
M000644187
Terms
ASP8273
Preferred Term
Term UI
T000945606
Date
08/07/2018
LexicalTag
LAB
ThesaurusID
NLM (2017)
ASP-8273
Term UI
T000945607
Date
08/07/2018
LexicalTag
LAB
ThesaurusID
NLM (2017)
page delivered in 0.004s